AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Bottom 1%
#4880 out of 4906 analysts
Average Return
-20.63%
Win Rate
28%39 out of 139
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phathom Pharmaceuticals IncPHAT | +285.51% | $2.76 | $10.64 | 2025-05-02 - 2025-06-13 | Buy |
Oyster Point Pharma IncOYST | +149.89% | $4.47 | $11.17 | 2022-07-18 - 2023-01-03 | Buy |
Phathom Pharmaceuticals IncPHAT | +110.28% | $5.06 | $10.64 | 2025-03-07 - 2025-06-13 | Buy |
Iveric Bio IncISEE | +80.13% | $20.94 | $37.72 | 2022-11-04 - 2023-05-02 | Buy |
FabrinetFN | +77.99% | $153.66 | $273.50 | 2023-08-22 - 2024-08-21 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lyra Therapeutics IncLYRA | 7 | Hold | $16.00 | +41.09% | Maintains | 6 days ago |
Phathom Pharmaceuticals IncPHAT | 10 | Buy | $20.00 | +87.97% | Reiterates | 7 days ago |
Akebia Therapeutics IncAKBA | 1 | Buy | $8.00 | +124.72% | Assumes | 12 days ago |
Diamedica Therapeutics IncDMAC | 5 | Buy | $10.00 | +173.97% | Reiterates | 18 days ago |
Unity Biotechnology IncUBX | 9 | Hold | $2.00 | +150.63% | Downgrades | 20 days ago |
Tarsus Pharmaceuticals IncTARS | 1 | Buy | $72.00 | +76.08% | Assumes | 20 days ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | a month ago |
Aldeyra Therapeutics IncALDX | 13 | Buy | $10.00 | +259.71% | Reiterates | a month ago |
Zenas Biopharma IncZBIO | 3 | Buy | $30.00 | +190.42% | Reiterates | a month ago |
Adverum Biotechnologies IncADVM | 6 | Buy | $30.00 | +1,119.51% | Reiterates | a month ago |
Mineralys Therapeutics IncMLYS | 8 | Buy | $42.00 | +193.30% | Reiterates | a month ago |
Surrozen IncSRZN | 3 | Buy | $32.00 | +237.66% | Reiterates | a month ago |
Lenz Therapeutics IncLENZ | 5 | Buy | $38.00 | +31.03% | Reiterates | a month ago |
Immunic IncIMUX | 4 | Buy | $10.00 | +1,142.24% | Reiterates | a month ago |
Fibrobiologics IncFBLG | 4 | Buy | $12.00 | +1,383.31% | Reiterates | 2 months ago |
Opus Genetics IncIRD | 12 | Buy | $8.00 | +724.74% | Reiterates | 2 months ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | +8.11% | Reiterates | 3 months ago |
Kodiak Sciences IncKOD | 4 | Hold | $3.00 | -22.68% | Reiterates | 3 months ago |
Opthea LtdOPT | 7 | Hold | $2.00 | -41.35% | Downgrades | 3 months ago |
Eyenovia IncEYEN | 16 | Hold | $2.00 | -18.03% | Reiterates | 3 months ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | +720.05% | Reiterates | 3 months ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.